First, we aimed to identify the overall effect of anti-interleukin-5 therapy on asthma, the asthma severity and baseline asthma therapy varied among studies (Table 2), so the population examined in this review was too heterogeneous to draw any conclusions about the general asthma population. This evidence concerns the gene IL5 and asthma.